ArticleBulletin of experimental biology and medicine2026
Effects of Intravenous and Subcutaneous Administration of Boron Particles on the Physiological Status of Immunodeficient SCID Mice.
Article in Bulletin of experimental biology and medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We studied the effects of a single administration of two types of boron particles coated with silane-PEG and produced either by laser fragmentation of boron-10 micropowder or by laser ablation of a solid target of enriched boron on body weight, the weight and histological structure of organs (kidney, liver, spleen, heart, lungs, and brain) and on blood parameters in immunodeficient SCID mice. The particles were injected subcutaneously and intravenously at doses of 10, 30, and 100 mg/kg. We observed a dose-dependent effect of boron particles on the lung and spleen weights, with larger particles inducing more pronounced changes. Intravenous administration of large particles at doses of 30 and 100 mg/kg was also associated with an increase in erythrocyte count. Histological examination revealed the presence of both large and small particles in the liver 2 weeks after a single intravenous administration at a dose of 100 mg/kg.
Indexed as
Identifiers
42509434What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.